AdipoLABs, 'Korea One Team' Formed to Promote K-Medical at China Nursing Expo

Medical device specialist AdipoLABs (CEO Han Sung-ho) joined hands with a number of domestic cancer treatment hospitals to showcase K-medical services and products focused on cancer treatment and care at the '8th China Chengdu International Nursing Service Industry Expo' held in Chengdu, Sichuan Province, China.

AdipoLABs set up an integrated booth called 'Korea Medical Center' at this expo. There, it ㅠboasted domestic cancer medical tourism and the high-frequency hyperthermia cancer treatment device 'REMISSION 1℃' to overseas visitors including China.

The hospitals that participated in Korea are specialized cancer treatment hospitals such as Seoul Oncare Hospital, Amirang Hospital, Yesan Myongji Hospital, and Chihyu Oriental Hospital. In addition, pharmaceutical and health food companies such as Nature's Farm, Red & Blue, and Medifuture also jumped in with both feet. On the Chinese side, about 200 companies participated including Sichuan Hospital Association, Chengdu Cancer Association, Chengdu Nursing Association, and Deokindang Group.

An AdipoLABs official said, "This was an opportunity to introduce our cancer treatment and pain relief medical device ' REMISSION 1℃'," adding, "This increases body temperature to over 40℃, helping blood circulation and boost immunity, and has actually been introduced to many cancer specialty hospitals." He added, "It has been proven to be effective in cancer treatment and pain management, and is receiving abundant attention from medical professionals overseas in Malaysia, Indonesia, and the Philippines."

At this expo, the 'International Conference on Cancer Treatment between Korea and China' was also held. Professor Jang Hong-seok of Seoul St. Mary's Hospital, Director Yoo Seung-mo of Yesan Myongji Hospital, Director Lee Chan-yong of Seoul Oncare, Director Ahn Seong-hwan of Yonsei Line, and CEO Han Sung-ho of AdipoLABs participated as speakers. From China, Vice Chairman Wang Chengquan of Sichuan Red Cross Society, Vice Chairman Mao Zenglin of Deokindang Holdings, Chairman Huang Jae-jun of Chengdu Emperor's Hospital, Director Shu Fengcheng of Dujiangyan Fengcheng Pain Hospital, and Dr. Kenny Yong of Malaysia gave academic presentations.

Han Sung-ho, CEO of AdipoLABs, took charge of the last session of the day. He presented the Korea-China medical tourism roadmap and also promoted the '2025 IVRA International Medical Conference' to be held at the Seoul St. Mary's Hospital Seongui Hall on June 22.

Han continued. "We plan to actively distribute advanced domestic medical devices and cancer treatment technologies to China and conduct aggressive marketing," adding, "I hope this event will lead to expanded medical cooperation between Korea and China."

Korean and Chinese officials are taking a commemorative photo at the '8th China Chengdu International Elderly Service Industry Expo'. (From the far left in the photo) Bae Dae-seung, CEO of Medifuture, Park Won-seo, Chairman of the Chengdu Korean-Chinese Cultural Association, Wang Qingquan, Chairman of the Chengdu Cancer Association, Eom Won-jae, Consul General of the Republic of Korea in Chengdu, Hwang Jae-gun, Chairman of the Chengdu Elderly Association, Han Sung-ho, CEO of AdipoLABs, Jang Hong-seok, Professor at Seoul St. Mary's Hospital, Ahn Seong-hwan, Director of Yonsei Line Hospital, Yan Bin, CEO of Guangzhou Ganganliyang Medical Technology Co., Ltd., Liu Qiang, Secretary General of Sichuan Hospital Association, and Wen Ze, CEO of Chengdu Century Gangbo Quansehui Co., Ltd. / Photo courtesy of AdipoLABs

Source: https://news.mt.co.kr/mtview.php?no=2025031316424176230&type=1